These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 37577379)

  • 1. Neurofeedback for tinnitus treatment: an innovative method with promising potential.
    Kleinjung T; Meyer M; Neff P
    Brain Commun; 2023; 5(4):fcad209. PubMed ID: 37577379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does it matter what is trained? A randomized controlled trial evaluating the specificity of alpha/delta ratio neurofeedback in reducing tinnitus symptoms.
    Jensen M; Alanis JCG; Hüttenrauch E; Winther-Jensen M; Chavanon ML; Andersson G; Weise C
    Brain Commun; 2023; 5(4):fcad185. PubMed ID: 37680692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurofeedback for tinnitus: study protocol for a randomised controlled trial assessing the specificity of an alpha/delta neurofeedback training protocol in alleviating both sound perception and psychological distress in a cohort of chronic tinnitus sufferers.
    Jensen M; Hüttenrauch E; Schmidt J; Andersson G; Chavanon ML; Weise C
    Trials; 2020 May; 21(1):382. PubMed ID: 32370767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining neurofeedback with source estimation: Evaluation of an sLORETA neurofeedback protocol for chronic tinnitus treatment.
    Güntensperger D; Kleinjung T; Neff P; Thüring C; Meyer M
    Restor Neurol Neurosci; 2020; 38(4):283-299. PubMed ID: 32675432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigating the Efficacy of an Individualized Alpha/Delta Neurofeedback Protocol in the Treatment of Chronic Tinnitus.
    Güntensperger D; Thüring C; Kleinjung T; Neff P; Meyer M
    Neural Plast; 2019; 2019():3540898. PubMed ID: 31049052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Where do the symptoms come from in depression? Topography and dynamics matter.
    Çatal Y; Northoff G
    Brain Commun; 2024; 6(2):fcae067. PubMed ID: 38515441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive resilience in Alzheimer's disease: from large-scale brain networks to synapses.
    Negro D; Opazo P
    Brain Commun; 2024; 6(1):fcae050. PubMed ID: 38425748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary progressive aphasia: in search of brief cognitive assessments.
    Matias-Guiu JA; Grasso SM
    Brain Commun; 2022; 4(5):fcac227. PubMed ID: 36128220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New inroads into the brain circuits and network dynamics behind sudden unexpected death in epilepsy.
    Gonzalez-Sulser A
    Brain Commun; 2022; 4(2):fcac097. PubMed ID: 35474854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating when (and how) hypertension may be 'good for your brain'.
    Magaki SD; Vinters HV
    Brain Commun; 2023; 5(2):fcad127. PubMed ID: 37113316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting early changes in Alzheimer's disease with graph theory.
    Pereira JB
    Brain Commun; 2020; 2(2):fcaa129. PubMed ID: 33225274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofeedback for treating tinnitus.
    Dohrmann K; Weisz N; Schlee W; Hartmann T; Elbert T
    Prog Brain Res; 2007; 166():473-85. PubMed ID: 17956812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vessel wall imaging: a promising enhancement in the management of inflammatory intracranial vasculopathy.
    Yang D; Elkind MSV
    Brain Commun; 2022; 4(5):fcac226. PubMed ID: 36128221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A toxic subset of soluble α-synuclein species in dementia with Lewy body.
    Castillo-Carranza DL
    Brain Commun; 2020; 2(1):fcaa016. PubMed ID: 32954281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eigenvector centrality and its variability over time are promising indicators of alterations in brain function due to early amyloid deposition.
    Skouras S
    Brain Commun; 2023; 5(3):fcad104. PubMed ID: 37151224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Connecting to motor recovery after stroke.
    Fowler JH; Kalaria RN
    Brain Commun; 2020; 2(2):fcaa067. PubMed ID: 32954324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Teflon hypothesis.
    Castellani RJ; Perry G
    Brain Commun; 2023; 5(4):fcad203. PubMed ID: 37492487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleoporin 98 mislocalization is a common feature in primary tauopathies.
    Nag N; Tripathi T
    Brain Commun; 2023; 5(2):fcad097. PubMed ID: 37033335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there cognitive and neuroimaging signatures in long COVID?
    Matias-Guiu JA; Díez-Cirarda M
    Brain Commun; 2023; 5(4):fcad189. PubMed ID: 37415777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer's disease.
    Toombs J; Zetterberg H
    Brain Commun; 2020; 2(1):fcaa054. PubMed ID: 32954304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.